Levels of bioactive endogenous lipids and health-related quality of life in Chronic Idiopathic Axonal Polyneuropathy
Background: Although neuropathic pain is a significant problem in polyneuropathy, the underlying molecular mechanisms are poorly understood. The endogenous bioactive lipids 2-arachidonoyl-glycerol (2-AG), oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and stearoylethanolamide (SEA) are known...
Main Authors: | Jonas Lind, Niclas Stensson, Björn Gerdle, Nazdar Ghafouri |
---|---|
Format: | Article |
Language: | English |
Published: |
Upsala Medical Society
2022-05-01
|
Series: | Upsala Journal of Medical Sciences |
Subjects: | |
Online Access: | https://ujms.net/index.php/ujms/article/view/8577/14602 |
Similar Items
-
Citicoline as a suggested novel adjuvant for painful diabetic polyneuropathy
by: Dico Gunawijaya, et al.
Published: (2021-06-01) -
Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol
by: David J. Kopsky, et al.
Published: (2022-10-01) -
Painful diabetic polyneuropathy: from clinical guidelines to daily practice
by: V. N. Khramilin, et al.
Published: (2019-08-01) -
Effects of vitamin D3 (cholecalciferol) supplementation on diabetic polyneuropathy in patients diagnosed with diabetes mellitus
by: Marton László, et al.
Published: (2023-09-01) -
Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?
by: Giorgia della Rocca, et al.
Published: (2021-03-01)